Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04305093 · ClinicalTrials.gov registry record
Data Mining: Precision Analytical Retrospective Data Correlation
A clinical trial of Hormone Disturbance and Obesity; Endocrine, sponsored by Precision Analytical.
- Completed
- Registry status
- 144,561
- Enrollment target
- 1
- Study location
NCT04305093 is a study of Hormone Disturbance and Obesity; Endocrine that has completed, run by Precision Analytical. The registered enrollment target is 144,561 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04305093, a study of Hormone Disturbance and Obesity; Endocrine, has completed, sponsored by Precision Analytical.
- COMPLETED
- Registry status
- 144,561 participants
- Enrollment target
- 1
- Study location
Study Summary
Data from previously analyzed clinical samples tested by Precision Analytical, Inc. will be mined to identify and select samples from patients reporting hormone supplement use. Patient demographics (BMI, for example), different therapies and expected changes in hormone levels will be analyzed and hormone metabolite patterns will be compared. Samples will be deidentified prior to analysis.
Conditions Studied
Study Locations (1)
Oregon
- Precision Analytical, Inc - McMinnville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144,561 participants |
| Start Date | 2019-12-15 |
| Est. Completion | 2023-03-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04305093
The ClinicalTrials.gov registry entry for NCT04305093 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 144,561 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Precision Analytical, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Hormone Disturbance appearing as the primary indexed condition, and to 0 interventions.
NCT04305093 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT04305093 about?
NCT04305093 is a clinical study titled "Data Mining: Precision Analytical Retrospective Data Correlation". Data from previously analyzed clinical samples tested by Precision Analytical, Inc. will be mined to identify and select samples from patients reporting hormone supplement use. Patient demographics (BMI, for example), different therapies and expected changes in hormone levels will be analyzed and ho...
What is the current status of trial NCT04305093?
This trial is currently completed. The enrollment target is 144,561 participants. The study started on 2019-12-15. Estimated completion is 2023-03-28.
What conditions does trial NCT04305093 study?
This clinical trial studies the following conditions: Hormone Disturbance, Obesity; Endocrine.
Who is sponsoring clinical trial NCT04305093?
This trial is sponsored by Precision Analytical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04305093 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hormone Disturbance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.